Stop illegal sales now: Jharkhand HC mandates prescriptions for cough syrups; State drug controller to ensure compliance and conduct raids

The Jharkhand High Court has imposed a strict regulation prohibiting the sale of cough syrups and intoxicating psychiatric medications without a doctor’s prescription. This decisive action comes in response to public interest litigation that uncovered alarming cases of substance abuse among students.

Ranchi: Jharkhand high court on Wednesday directed the govt and the state drug controller to ensure that cough syrups and other psychiatric medicines which cause intoxication are not sold without medical prescriptions in the state. A division bench of Chief Justice Tarlok Singh Chauhan and Justice Rajesh Shankar was hearing a public interest litigation filed by Sunil Kumar Mahto on open sale of cough syrups in the city.

The syrups and other psychotic medicines are sold without medical prescriptions illegally, Mahto said in his petition.

Mahto went on to inform the court that cough syrup and other intoxicating medicines are illegally sold by medicine shops in the capital city. The cough syrups and medicines are consumed by school students and result in severe substance and medicine abuse taking a toll on their mental and physical health.

The bench taking a serious note of the matter ordered the state drug controller to ensure that no medical store should sell cough syrups and intoxicating medicines without proper medical prescription. The court also ordered the drug controller to conduct frequent raids and check the stocks of medicines of stores and pharmaceutical companies operating in the state.

The court directed the state govt to file a compliance report. The case will again be heard on Dec 12. The HC also ordered the drug controller to conduct frequent raids and check the stocks of medicines of stores and pharmaceutical companies operating in the state

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework